Congress is venturing into unknown and potentially explosive territory with the first House GOP-led investigation into COVID-19 vaccines.
Why it matters: It’s expected to be a showdown across the spectrum of views on vaccine safety and efficacy, from attempting to undermine public faith in them to trying to bolster confidence.
The details: The Oversight Select Subcommittee on the Coronavirus Pandemic has been given a broad writ to investigate a wide array of topics from the virus’ origins to federal COVID restrictions to the pandemic’s economic impact.
The state of play: In interviews with Axios, Republicans expressed a wide range of views on how they want to approach the investigations into vaccines.
What we’re watching: Greene, who is known for her ability to capture public attention, has already made clear how she wants to use the public perch the panel will afford her.
What they’re saying: “We want to look at the effectiveness of these vaccines,” Wenstrup told Axios.
The other side: Rep. Raul Ruiz (D-Calif.), the ranking member on the panel, told Axios, “There’s no doubt that vaccines work,” adding that “it would be interesting to look at the efficiency of developing a vaccine for a novel virus … the equity in vaccine distribution, the lives saved and productivity gained by having vaccines.”
The bottom line: The CDC, which could be a target of the panel’s investigations, has published data from multiple studies that shows the COVID’s vaccine safety and effectiveness against severe illness, hospitalization and death.
We wish to inform readers that the beforementioned content is not our own, and neither do we claim it to be as such. All credit goes to https://www.axios.com/ for producing the original content. They have our endorsement.